The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus

被引：51
作者：
Beyan, E
Beyan, C [1 ]
Demirezer, A
Ertugrul, E
Uzuner, A
机构：
[1] Gulhane Mil Med Acad, Dept Hematol, TR-06010 Etlik, Turkey
[2] Gulhane Mil Med Acad, Dept Internal Med, Numune Educ & Res Hosp, TR-06010 Etlik, Turkey
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2003年 / 32卷 / 04期
关键词：
systemic lupus erythematosus; serum ferritin; SLEDAI; acute phase response;
D O I：
10.1080/03009740310003712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: The aim of this study is to investigate the relationship between serum ferritin levels and disease activity in patients with systemic lupus erythematosus (SLE). Methods: Serum ferritin levels of 72 SLE patients were measured. The SLE patients were subdivided into two groups according to SLE disease activity index (SLEDAI) as less than or equal to10 and greater than or equal to11. The results were compared with 31 patients with rheumatoid arthritis (RA). 36 patients among 72 with SLE were evaluated before and after treatment. Results: Serum levels of ferritin in SLE patients were higher than RA patients (p < 0,001). There was a significant difference in ferritin levels before and after treatment. The levels of ferritin in SLE were positively correlated with SLEDAI scores. Patients with SLEDAI scores ≥11 had significantly higher serum ferritin levels. Conclusion: Serum ferritin levels may be a useful marker of disease activity in SLE patients.
引用
收藏
页码：225 / 228
页数：4
相关论文
共 50 条
  • [21] The Relationship Between Systemic Lupus Erythematosus Activity an Persistent Positive Antiphospholipid Antibodies
    Sarabi, Zhaleh Shariati
    Sahebari, Maryam
    Rezaie, Ali Etemad
    Norouzi, Mohammad Taghi
    Hashemzadeh, Kamila
    Mirfeizi, Zahra
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2018, 14 (02) : 145 - 152
  • [22] Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage
    Brunner, HI
    Jones, OY
    Lovell, DJ
    Johnson, AM
    Alexander, P
    Klein-Gitelman, MS
    [J]. LUPUS, 2003, 12 (08) : 600 - 606
  • [23] Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
    Fernandez-Cladera, Yolanda
    Gomez-Bernal, Fuensanta
    Garcia-Gonzalez, Maria
    Quevedo-Abeledo, Juan C.
    Gonzalez-Rivero, Agustin F.
    de Vera-Gonzalez, Antonia
    Martin-Gonzalez, Candelaria
    Nunes-Andrade, Ana L.
    Lopez-Mejias, Raquel
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    [J]. BIOMOLECULES, 2023, 13 (08)
  • [24] Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus
    Pawlak-Bus, Katarzyna
    Schmidt, Wiktor
    Leszczynski, Piotr
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [25] Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
    Christopher Sjöwall
    Anders A Bengtsson
    Gunnar Sturfelt
    Thomas Skogh
    [J]. Arthritis Res Ther, 6
  • [26] Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
    Sjöwall, C
    Bengtsson, AA
    Sturfelt, G
    Skogh, T
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (02) : R87 - R94
  • [27] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus
    Yip, Jonathan
    Aghdassi, Elaheh
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna D.
    Urowitz, Murray B.
    Fortin, Paul R.
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1667 - 1672
  • [28] Systemic Lupus Erythematosus activity and serum bilirubins
    dos Santos, Brenda Hernandes
    de R Almeida, Camila Monteiro
    Skare, Thelma L.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2013, 38 (04): : 242 - 246
  • [29] Association between Serum Levels of C3 and C4 with Disease Activity in Systemic Lupus Erythematosus Patients
    Idayu, Siti H.
    Kamaliah, M. D.
    Suryani, Noor M. A.
    Maraina, Che C. H.
    [J]. INTERNATIONAL MEDICAL JOURNAL, 2012, 19 (04): : 299 - 301
  • [30] Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort
    Geraldino-Pardilla, L.
    Perel-Winkler, A.
    Miceli, J.
    Neville, K.
    Danias, G.
    Nguyen, S.
    Dervieux, T.
    Kapoor, T.
    Giles, J.
    Askanase, A.
    [J]. LUPUS, 2019, 28 (07) : 862 - 867
12345